Home » Stocks » INTC

Intel Corporation (INTC)

Stock Price: $44.11 USD -0.14 (-0.32%)
Updated Oct 30, 2020 4:00 PM EDT - Market closed
After-hours: $44.27 +0.16 (0.36%) Oct 30, 7:59 PM

Stock Price Chart

Key Info

Market Cap 180.76B
Revenue (ttm) 78.10B
Net Income (ttm) 21.95B
Shares Out 4.10B
EPS (ttm) 5.11
PE Ratio 8.63
Forward PE 9.41
Dividend $1.32
Dividend Yield 2.99%

Stock Quote

Trading Day Oct 30, 2020
Last Price $44.11
Previous Close $44.25
Change ($) -0.14
Change (%) -0.32%
Day's Open 44.13
Day's Range 43.61 - 44.80
Day's Volume 46,794,171
52-Week Range 43.61 - 69.29

More Stats

Market Cap 180.76B
Enterprise Value 199.07B
Earnings Date (est) Jan 28, 2021
Ex-Dividend Date Aug 6, 2020
Shares Outstanding 4.10B
Float 4.10B
EPS (basic) 5.14
EPS (diluted) 5.11
FCF / Share 4.85
Dividend $1.32
Dividend Yield 2.99%
Earnings Yield 11.58%
FCF Yield 11.24%
Payout Ratio 25.40%
Shares Short 118.19M
Short Ratio 3.72
Short % of Float 2.89%
Beta 0.72
PE Ratio 8.63
Forward PE 9.41
P/FCF Ratio 8.89
PS Ratio 2.31
PB Ratio 2.43
Revenue 78.10B
Operating Income 24.59B
Net Income 21.95B
Free Cash Flow 20.32B
Net Cash -18.31B
Net Cash / Share -4.47
Gross Margin 53.96%
Operating Margin 31.49%
Profit Margin 28.10%
FCF Margin 26.02%
ROA 11.13%
ROE 29.50%
ROIC 22.10%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (41)

Buy 11
Overweight 1
Hold 19
Underweight 3
Sell 7

Analyst Consensus: Overweight

Price Target

(22.99% upside)
Current: $44.11
Target: 54.25
*Average 12-month price target from 34 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth1.58%12.89%5.68%7.28%-0.92%6%-1.19%-1.22%23.79%-
Gross Profit42,14043,73739,09836,23334,67935,60931,52133,15133,75728,491
Operating Income22,03523,31618,05013,13314,00215,34712,29114,63817,47715,588
Net Income21,04821,0539,60110,31611,42011,7049,62011,00512,94211,464
Shares Outstanding4,4174,6114,7014,7304,7424,9014,9704,9965,2565,555
Earnings Per Share4.714.481.992.122.332.311.892.132.392.01
EPS Growth5.13%125.13%-6.13%-9.01%0.87%22.22%-11.27%-10.88%18.91%-
Dividend Per Share1.
Dividend Growth5%11.32%3.65%8.33%6.67%0%3.45%11.25%24.13%-
Operating Cash Flow33,14529,43222,11021,80819,01820,41820,77618,88420,96316,692
Capital Expenditures-16,213-15,181-11,778-9,625-7,326-10,105-10,711-11,027-10,764-5,207
Free Cash Flow16,93214,25110,33212,18311,69210,31310,0657,85710,19911,485
Cash & Equivalents13,12311,65014,00217,09925,31314,05420,08718,16214,83721,885
Total Debt29,00126,35926,81325,28322,67013,65513,44613,4487,3312,115
Net Cash / Debt-15,878-14,709-12,811-8,1842,6433996,6414,7147,50619,770
Book Value77,50474,56369,01966,22661,08555,86558,25651,20345,91149,430
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Intel Corporation
Country United States
Employees 111,300
CEO Robert Holmes Swan

Stock Information

Ticker Symbol INTC
Stock Exchange NASDAQ
Sector Technology
Industry Semiconductors
Unique Identifier NASDAQ: INTC


Intel Corporation designs, manufactures, and sells essential technologies for the cloud, smart, and connected devices worldwide. The company operates through DCG, IOTG, Mobileye, NSG, PSG, CCG, and All Other segments. It offers platform products, such as central processing units and chipsets, and system-on-chip and multichip packages; and non-platform or adjacent products comprising accelerators, boards and systems, connectivity products, and memory and storage products. The company also provides Internet of things products, including high-performance compute solutions for targeted verticals and embedded applications; and computer vision and machine learning-based sensing, data analysis, localization, mapping, and driving policy technology. It serves original equipment manufacturers, original design manufacturers, and cloud service providers. The company has collaborations with UC San Francisco's Center for Digital Health Innovation, Fortanix, and Microsoft Azure to establish a computing platform with privacy-preserving analytics to accelerate the development and validation of clinical algorithms. Intel Corporation was founded in 1968 and is headquartered in Santa Clara, California.